Assignee
AFFYXELL THERAPEUTICS CO LTD
KR·0 granted patents·2 pending applications·0 citations·filing 2023–2023
Top patents by PatentIndex Score
2 records- 0167US2026022160A1Genetically modified cells comprising a nucleic acid encoding a cd40l binding agent and uses thereofAFFYXELL THERAPEUTICS CO LTD·Filed 2023·Application pending·0 cites
- 0267US2026022343A1Genetically modified cells comprising a nucleic acid encoding a cd40l binding agent and uses thereofAFFYXELL THERAPEUTICS CO LTD·Filed 2023·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when AFFYXELL THERAPEUTICS CO LTD files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →